Enzon Pharmaceuticals's total assets for Q were $47.70M, an increase of 1.50% from the previous quarter. ENZN total liabilities were $1.71M for the fiscal quarter, a 322.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.